Credit Suisse Upgrades Biogen (BIIB) to Outperform
Tweet
Share
E-mailGet Alerts BIIB Hot Sheet
Price: $217.56 +1.50%
Rating Summary:
28 Buy, 15 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
28 Buy, 15 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Credit Suisse upgraded Biogen (NASDAQ: BIIB) from Neutral to Outperform. PT increased from $100 to $126.
For more ratings news on Biogen click here and for the rating history of Biogen click here.
Shares of Biogen closed at $98.65 yesterday.
For more ratings news on Biogen click here and for the rating history of Biogen click here.
Shares of Biogen closed at $98.65 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Biogen (BIIB) call put ratio 3.7 calls to 1 put with a focus on September calls
- B.Riley Upgrades RF Industries Ltd. (RFIL) to Buy
- Morgan Stanley Upgrades Ternium S.A. (TX) to Overweight
Create E-mail Alert Related Categories
UpgradesRelated Entities
Credit SuisseSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
